McKesson Corporation (MCK) : Klcm Advisors scooped up 1,130 additional shares in McKesson Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 56,535 shares of McKesson Corporation which is valued at $11,115,912.McKesson Corporation makes up approximately 3.63% of Klcm Advisors’s portfolio.
Other Hedge Funds, Including , Geneva Advisors reduced its stake in MCK by selling 1,196 shares or 3.23% in the most recent quarter. The Hedge Fund company now holds 35,856 shares of MCK which is valued at $7,050,007. McKesson Corporation makes up approx 0.13% of Geneva Advisors’s portfolio.Janney Montgomery Scott reduced its stake in MCK by selling 2,420 shares or 5.75% in the most recent quarter. The Hedge Fund company now holds 39,694 shares of MCK which is valued at $7,726,834. McKesson Corporation makes up approx 0.12% of Janney Montgomery Scott’s portfolio.Tdam Usa reduced its stake in MCK by selling 4,302 shares or 5.7% in the most recent quarter. The Hedge Fund company now holds 71,181 shares of MCK which is valued at $13,856,093. McKesson Corporation makes up approx 0.66% of Tdam Usa’s portfolio.Spot Trading L.l.c reduced its stake in MCK by selling 197 shares or 79.12% in the most recent quarter. The Hedge Fund company now holds 52 shares of MCK which is valued at $10,147.Msi Financial Services Inc boosted its stake in MCK in the latest quarter, The investment management firm added 44 additional shares and now holds a total of 4,271 shares of McKesson Corporation which is valued at $841,045. McKesson Corporation makes up approx 0.03% of Msi Financial Services Inc’s portfolio.
McKesson Corporation opened for trading at $195.35 and hit $197.08 on the upside on Monday, eventually ending the session at $196.12, with a gain of 0.45% or 0.88 points. The heightened volatility saw the trading volume jump to 6,96,353 shares. Company has a market cap of $44,265 M.
On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.
Investors should note that on Jul 26, 2016, McKesson Corporation announced a cash dividend of $0.2800. The company’s management has announced Aug 30, 2016 as the ex-dividend date and fixed the record date on Sep 1, 2016. The payable date has been fixed on Oct 3, 2016.
Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 197 from a previous price target of $174 .Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.